ArticleClinical and experimental pediatrics2021

The protective effect of CXC chemokine receptor 2 antagonist on experimental bronchopulmonary dysplasia induced by postnatal systemic inflammation.

Seung Hyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.